Levobupivacaine
CAS: 27262-47-1
Rif. TM-T1787
5mg | 52,00 € | ||
10mg | 67,00 € | ||
25mg | 96,00 € | ||
50mg | 138,00 € | ||
100mg | 190,00 € | ||
200mg | 278,00 € | ||
500mg | 476,00 € | ||
1ml*10 (DMSO) | 49,00 € |
Informazioni sul prodotto
- (-)-(S)-Bupivacaine
- (-)-Bupivacaine
- (2S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
- (2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- 2',6'-Pipecoloxylidide, 1-butyl-, (-)-
- 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (S)-
- 2′,6′-Pipecoloxylidide, 1-butyl-, (-)-
- <span class="text-smallcaps">L</span>-(-)-Bupivacaine
- Chirocain
- L-(-)-Bupivacaine
- Vedi altri sinonimi
Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur.
Proprietà chimiche
Richiesta tecnica su: TM-T1787 Levobupivacaine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.